EDGAR Filing Documents for 0000818686-10-000065

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0000818686-10-000065

Filing Date

2010-06-29

Accepted

2010-06-29 09:05:39

Documents

Period of Report

2009-04-01

Document Format Files

Seq	Description	Document	Type	Size
1	TEVA ANNOUNCES APPROVAL OF GENERIC EFFEXOR XR?	venlafaxine290610.htm	6-K	10823
2	TEVA ANNOUNCES APPROVAL OF GENERIC EFFEXOR XR?	venlafaxine290610.pdf	6-K	40585
4	GRAPHIC	image001.jpg	GRAPHIC	3735
	Complete submission text file	0000818686-10-000065.txt		73668

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)